ResMed | RMD - Cash And Equivalent


ResMed reported $1.66B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Ansell USD 238.3M 674M Jun/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Cochlear AUD 275.7M 107.4M Jun/2025
CSL USD 2.16B 633M Jun/2025
Fisher & Paykel Healthcare NZD 461.1M 371.2M Jun/2026
Healius AUD 60.1M 25.6M Jun/2024
Integral Diagnostics AUD 17.99M 15.86M Dec/2023
Mayne Pharma AUD 110.07M 838K Jun/2024
Nanosonics AUD 161.29M 156.45M Jun/2025
Polynovo AUD 29.21M 16.7M Dec/2025
Ramsay Health Care AUD 784.4M 443.3M Jun/2025
Regis Healthcare AUD 192.46M 127.56M Jun/2025
ResMed USD 1.66B 243.44M Mar/2026
Sigma Healthcare AUD 16.65M 3.68M Jan/2023
Sonic Healthcare AUD 645M 25.39M Jun/2024
Telix Pharmaceuticals AUD 141.87M 65.29M Dec/2025